TABLE 3.
Outcomes of early cancer.
| Multiple incident cancers (n, %) | Number of cancers (n) | First cancer causing allograft failure (n, %) | First cancer causing Death (n, %) | |
|---|---|---|---|---|
| Cancer first 12 months | 39 (16.0) | 243 | 3 (1.2) | 77 (31.7) |
| Melanoma | 29 | 0 | 7 (24.1) | |
| Urinary tract a | 44 | 1 (2.3) | 7 (15.9) | |
| Lymphoproliferative disease | 62 | 1 (1.6) | 25 (40.3) | |
| Colorectal | 12 | 0 | 7 (58.3) | |
| Other GI b | 17 | 0 | 14 (82.4) | |
| Lung | 8 | 0 | 6 (75.0) | |
| Brain | 3 | 0 | 1 (33.3) | |
| Genital c | 15 | 0 | 1 (6.7) | |
| Prostate | 9 | 0 | 1 (11.1) | |
| Breast | 12 | 0 | 0 | |
| Thyroid | 7 | 0 | 0 | |
| Lip | 1 | 0 | 0 | |
| Unknown origin | 2 | 0 | 2 (100.0) | |
| Others | 22 | 1 (4.5) | 6 (27.3) |
Cancer occurring >12 months post-transplant: 13.4% multiple cancers, 1.2% first cancer causing allograft failure and 31.7% first cancer causing death.
a
Cancers of the kidney, ureters and bladder.
b
Other gastrointestinal tract cancers (including gall bladder, small intestine, bile duct, pancreas, liver, stomach, esophagus).
c
Cervix, ovaries, uterus, penile.